Z-0310-2022 Class II Ongoing
FDA device recall Z-0310-2022 was initiated by DRG International, Inc. on Oct 18, 2021 and is designated Class II. Reason for recall: Firm has identified two lots of product that do not meet product shelf life, resulting in failed Controls. The clinical impact may be a delay in diagnosis and a consumption of patient samples. The recall status is ongoing. Affected quantity: 314 total (270 US).
Recall details
- Product Type
- Devices
- Report Date
- Dec 8, 2021
- Initiation Date
- Oct 18, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 314 total (270 US)
Product description
Total Thyroxine (T4) ELISA; REF EIA-1781
Reason for recall
Firm has identified two lots of product that do not meet product shelf life, resulting in failed Controls. The clinical impact may be a delay in diagnosis and a consumption of patient samples.
Distribution pattern
Domestic: NY; International: TZ, VN, BD, CO, TT, YE, BO, DE, SV, GE, PY, TG, RU/UA, NI, DO, NG, EG & CM
Code information
lot#: RN-60923 expiration date 12/31/2021; RN-60831 expiration date 12/31/2021
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0310-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026